Method shows promise for early detection of pancreatic cancer
...ncer in asymptomatic patients, said Vadim Backman, developer of the technology and professor of biomedical engineering at Northwesterns Robert R. McCormick School of Engineering and Applied Science. Backman and Yang Liu, a former graduate student of Backmans, teamed up with physicians at Evanston Northwester...Researchers begin randomized double-blind trial of airway bypass treatment for emphysema
... Joel Cooper, M.D., a pioneer in thoracic surgery, developer of the airway bypass procedure and Chief of the Division of Thoracic Surgery at the University of Pennsylvania Health System. Dr. Cooper is also a co-principal investigator of the EASE Trial and a consultant to Broncus. "By creating new pathways fo...UCSF brain tumor vaccine trial shows promising results
...ertainly warranted to evaluate efficacy. Brem is a developer of the first approved local therapy for glioma. The UCSF clinical trial is a phase1/2 study designed to establish the feasibility, safety and preliminary efficacy of vaccination in patients with recurrent, high-grade glioma. The trial involves two ...National Inventors Hall of Fame announces 2007 inductees
... hepatitis A & B. Considered the greatest vaccine developer of the 20th century, during his life he was credited with saving more lives than any living scientist. Leroy Hood (1938- ) DNA sequencer Hood's DNA sequencer has played a crucial role in the biotech industry, greatly accelerating the progress ...Physicians enlisted in efforts to keep demented drivers off the road
...d its various stages. In another section, workshop developer David B. Carr, M.D., associate professor of medicine and of neurology, explains an American Medical Association (AMA) recommendation that physicians risk-stratify their patients, grouping them on the basis of their clinical observations into safe, un...'Umbrella' valve provides a potential alternative to lung surgery
... research trial that is currently sponsored by the developer of the IBV TM Valve, Spiration, Inc. "Although there is no cure for emphysema, proper treatment can improve a patient's exercise capacity, overall quality of life, and may result in longer survival," said Mark J. Rosen, MD, FCCP, President of the ...Supertron raises $3.5 million in Series C Financing
...echnologies Inc. ( www.supertron.com ), a leading developer of next-generation solutions for high-performance preclinical and clinical Magnetic Resonance Imaging (MRI) coils and probes announced today successfully financing $3.5 million with Amphion Innovations PLC. Supertron is based in the Enterprise Devel...New radiation protection technique results in reduced physician exposure
...ntrol for panning, according to Martin Magram, MD, developer of the new technique and assistant professor in the department of diagnostic radiology. Dr. Magram recorded radiation exposure to various parts of the physician's body in a new study using the technique during coronary angiography on 25 patients. ...Medical jargon is not unequivocal
...tem is. Then they do not need to blindly trust the developer of the system. If everyone uses the same medical terms, it is much easier to use the data of all patients for improving patient care or for epidemiological research. Then a search query on the basis of a certain term will no longer incorrectly omit ...Tool to reduce elderly driving deaths nationwide
...litary simulation, Raydon Corporation is a leading developer and supplier of high-tech, low-cost driving simulators, which are currently used in dozens of states for novice driver education and driver improvement. Raydon has previously worked with organizations such as the National Safety Council on driving si...The long research road to a new vaccine
... Plotkin, an emeritus professor at Wistar, was the developer of a number of vaccines, including the rubella vaccine responsible for eradicating that disease in the United States, according to the Centers for Disease Control. "This new vaccine against an important disease of childhood is the result of two leadi...U of MN study shows nicotine vaccine has promise for helping smokers quit
...stitute of Drug Abuse and Nabi Biopharmaceuticals, developer of the NicVax vaccine.Paul Pentel, M.D., with Hennepin County Medical Center in Minneapolis, previously evaluated the vaccine in rats and found that the vaccine-induced antibodies led to reduced levels of nicotine in the brain. His research also show...New gene silencing therapy for cervical cancer
...d. Professor Ian Frazer, Director of the CICR and developer of a vaccine for cervical cancer, said the research represented a significant step towards developing gene therapy for cervical cancer. Cervical cancer is the leading cause of cancer death in women aged 25-50 worldwide and causes around 300 deaths p...Compound from marine bacteria shows potential as multiple myeloma therapy
...icials of Nereus Pharmaceuticals in San Diego, the developer of NPI-0052. The compound will be tested as a single agent and subsequently in combination with other treatments. Multiple myeloma is a currently incurable cancer of the bone marrow that causes a plunge in the production of vital red and white blood...Research results from the 'Era of Hope' Department of Defense breast cancer research program meeting
...f Pennsylvania Medical School in Philadelphia, and developer of the device. "It would provide an indication of early signs of breast cancer that need to be followed up by a doctor." The device measures oxygenation rather than blood volume to detect hypermetabolism -- the speedier growth rate of cancer cells...Children need better cancer drugs, says expert panel
...ncer Institute should assume responsibility as the developer of last resort. As one model of a public-private partnership focused on a health condition, the IOM report describes the Therapeutics Development Program established by the Cystic Fibrosis Foundation to support the research and development of new dru...Saving virtual lives with nanobots goal of UH-led project
... in the simulated environment. As head software developer for Associate Professor Ioannis Pavlidis' Computational Physiology Laboratory at UH, Dowdall is well prepared for this challenge. Pavlidis has gained a reputation for his work in medical imaging, bioinformatics, robotics, computational biomedicine a...Orqis Medical receives unconditional FDA approval for pivotal trial of percutaneous CHF therapy
...Calif. April 26, 2005 Orqis Medical Corporation, developer of the novel and proprietary catheter-based Cancion cardiac recovery system (CRS TM ) to treat congestive heart failure (CHF), today announced U.S. Food and Drug Administration (FDA) unconditional approval for researchers to treat up to 200 CHF patie...